Efficacy and Safety Assessment of Azyter (T1225) in Peri-Operative Antibio-Prophylaxis (ocular surface decontamination) for Cataract Surgery: a pilot phase II randomised controlled trial

Trial Profile

Efficacy and Safety Assessment of Azyter (T1225) in Peri-Operative Antibio-Prophylaxis (ocular surface decontamination) for Cataract Surgery: a pilot phase II randomised controlled trial

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2013

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Postoperative infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jul 2012 Additional trial location (Spain) added as reported by European Clinical Trials Database record.
    • 04 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top